Given Imaging share price spikes as it mulls sale
This article was originally published in Clinica
Executive Summary
Israeli capsule developer Given Imaging has said that it is considering putting itself up for sale, leading to a jump in its share price on the Nasdaq Global Select market. The firm's stock was trading as high as $15.50 on 17 October, the day it put out the statement, eventually closing at $15.27, up 2% from the previous day.